Drug Profile
Interferon-con1 gene therapy
Alternative Names: ad5/IFN; IFN-con1 gene therapyLatest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Cytokine genes; Gene therapies; Interferons
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 20 Feb 1997 Preclinical development for Cancer in USA (Injection)